Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Ventech in connection with their investment in Mindler
Mandate

Vinge has advised Ventech in connection with their investment in Mindler

April 14, 2020

Vinge has advised Ventech, a leading Seed & Series A-focused European venture capital firm, in connection with their investment in Mindler, Sweden’s largest digital service for mental health.

The series A round, which raised EUR 8 million, was led by Ventech and co-led by Schibsted Growth. The funds raised will be used to accelerate Mindler’s European expansion and to reinforce the startup’s organizational growth and platform development.
 
Vinge’s team consisted of Johan Larsson, Maria Dahlin Kolvik, Karl-Hugo Engdahl and Elsie Nassar.

 

Related

Vinge advises Trianon in connection with directed share issue and tender offer for subordinated sustainable capital securities

 Vinge advises Fastighets Aktiebolaget Trianon (publ) in connection with a directed share issue of SEK 184 million and a tender offer for outstanding subordinated perpetual floating rate callable sustainable capital securities.
April 19, 2024

Vinge advises Blackstone in connection with its investment in Winthrop Technologies

 Vinge, as local Swedish counsel, advised Blackstone Tactical Opportunities and affiliated funds (“Blackstone”) in connection with a strategic partnership with Winthrop Technologies Limited (“Winthrop Technologies”).
April 17, 2024

Vinge has advised Hansa Biopharma in connection with a directed share issue of SEK 372 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of SEK 372 million before transaction costs. Hansa Biopharma is a commercial-stage biopharmaceutical company pioneering the development and commercialization of innovative, lifesaving and life altering treatments for patients with rare immunological conditions. Hansa Biopharma’s ordinary share is listed on Nasdaq Stockholm.
April 16, 2024